Biohaven Q2 Adj $(3.50) Misses $(1.77) Estimate
Portfolio Pulse from Benzinga Newsdesk
Biohaven (NYSE:BHVN) reported a Q2 loss of $(3.50) per share, significantly missing the analyst consensus estimate of $(1.77) by 97.74%. This represents a 180% increase in losses compared to $(1.25) per share from the same period last year.
August 08, 2024 | 9:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biohaven reported a Q2 loss of $(3.50) per share, missing the analyst consensus estimate of $(1.77) by 97.74%. This marks a 180% increase in losses compared to the same period last year.
The significant miss on earnings estimates and the substantial increase in losses compared to the previous year are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100